the National Key R&D Program of China(grant No.2022YFE0202500);Distinguished Young Scholars of the National Natural Science Foundation of China(grant No.T2222022);National Key Research and Development Program of China(grant No.2021YFC2302400,2021YFC2302600);Major Program of the National Natural Science Foundation of China(grant No.T2394503,T2394501);Key Project of the National Natural Science Foundation of China(grant No.32030062),CAS Project for。
Tumor immunotherapy,particularly cancer vaccines,holds promise for combating cancer by harnessing tailored immune responses against malignant cells.However,conventional approaches face challenges in efficiently delive...